PIER FRANK: Open Payments
NPI 1538135132 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 12 payments from 8 companies in 2025. Trend: 2023 $232 · 2024 $263 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: TZIELD, Kerendia, INGREZZA, Cologuard Collection Kit, CAPLYTA, MOUNJARO, AUSTEDO XR, FARXIGA.
Industry payments across FL — which companies pay providers there.
